View More View Less
  • 1 Pécsi Tudományegyetem, Általános Orvostudományi Kar I. Belgyógyászati Klinika Pécs Ifjúság u. 13. 7643
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

Mivel a hepatitis B- és C-vírus- (HBV-, HCV-) fertőzés döntő szerepet játszik a hepatocellularis carcinoma (HCC) keletkezésében, a HBV és HCV okozta hepatitis és cirrhosis megelőzése és kezelése egyben a HCC prevencióját is jelentheti. A HCC primer prevencióját képviseli a HBV elleni vakcináció és a donorok szűrése HBV- és HCV-markerekre. A szekunder prevencióhoz sorolható az interferonalapú és/vagy nukleozidanalóg anti-HBV- és anti-HCV-terápia, a cirrhosisos betegek HCC irányában történő alfa-foetoprotein + ultrahang szűrése, valamint a HCC kuratív reszekciója/ablatiója utáni adjuváns antivirális kezelés. Várható, hogy a HBV-vakcináció világszerte történő széles körű alkalmazása, továbbá az optimalizált individuális antivirális kezelésmódok, az új nukleozidanalógok és HCV-specifikus proteáz- és polimerázgátlók révén előrelépés történik nemcsak a vírushepatitisek megelőzésében és terápiájában, hanem a HCC prevenciójában is a nem túl távoli jövőben.

  • Wright, T. L.: Antiviral therapy and primary and secondary prevention of hepatocellular carcinoma. Hepatol. Res., 2007, 37 (Suppl. 2) , S294–298.

    Wright T. L. , 'Antiviral therapy and primary and secondary prevention of hepatocellular carcinoma ' (2007 ) 37 Hepatol. Res. : S294 -298.

    • Search Google Scholar
  • Schaff Zs., Lotz G., Kiss A.: Vírusindukált hepatokarcinogenezis. Magy. Tud., 2005, 10 , 1187–1192.

    Kiss A. , 'Vírusindukált hepatokarcinogenezis ' (2005 ) 10 Magy. Tud. : 1187 -1192.

  • Tan, A., Yeh, S-H., Liu, C-J. és mtsai: Viral hepatocarcinogenesis: from infection to cancer. Liver Internat., 2008, 28 , 175–188.

    Liu C-J. , 'Viral hepatocarcinogenesis: from infection to cancer ' (2008 ) 28 Liver Internat. : 175 -188.

    • Search Google Scholar
  • Beasley, R. P., Hwang, L. Y., Lin, C. C. és mtsai: HCC and HBV. A prospective study of 22 707 men in Taiwan. Lancet, 1981, 2 , 1129–1133.

    Lin C. C. , 'HCC and HBV. A prospective study of 22 707 men in Taiwan ' (1981 ) 2 Lancet : 1129 -1133.

    • Search Google Scholar
  • Beasley, R. P.: Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer, 1988, 61 , 1942–1956.

    Beasley R. P. , 'Hepatitis B virus. The major etiology of hepatocellular carcinoma ' (1988 ) 61 Cancer : 1942 -1956.

    • Search Google Scholar
  • Michielsen, P. P., Francque, S. M., van Dongen, J. L.: Viral hepatitis and hepatocellular carcinoma. World J. Surg. Oncol., 2005, 3 , 27. DOI:10.1186/1477-7819-3-27

    Dongen J. L. , 'Viral hepatitis and hepatocellular carcinoma ' (2005 ) 3 World J. Surg. Oncol. : 27 -.

    • Search Google Scholar
  • Chang, M. H., Chen, C. J., Lai, M. S. és mtsai: Hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma. in children. N. Eng. J. Med., 1997, 336 , 1855–1859.

    Lai M. S. , 'Hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma. in children ' (1997 ) 336 N. Eng. J. Med. : 1855 -1859.

    • Search Google Scholar
  • Chang, M. H., Chen, T. H. H. G., Hsu, H. M. és mtsai: Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin. Cancer Res., 2005, 11 , 7953–7957.

    Hsu H. M. , 'Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems ' (2005 ) 11 Clin. Cancer Res. : 7953 -7957.

    • Search Google Scholar
  • Yoshizawa, H.: Hepatocellular carcinoma associated with hepatitits C virus infection in Japan: Projection to other countries in the foreseeable future. Oncology, 2002, 62 (Suppl. 1) , 8–17.

    Yoshizawa H. , 'Hepatocellular carcinoma associated with hepatitits C virus infection in Japan: Projection to other countries in the foreseeable future ' (2002 ) 62 Oncology : 8 -17.

    • Search Google Scholar
  • Niederau, C., Heintges, T., Lange, S. és mtsai: Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. New Eng. J. Med., 1996, 334 , 1422–1427.

    Lange S. , 'Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B ' (1996 ) 334 New Eng. J. Med. : 1422 -1427.

    • Search Google Scholar
  • Lau, D. T., Everhardt, J. E., Kleiner, D. E. és mtsai: Long-term follow-up of patients wih chronic hepatitis B treated with interferon alfa. Gastroenterology, 1997, 113 , 1660–1667.

    Kleiner D. E. , 'Long-term follow-up of patients wih chronic hepatitis B treated with interferon alfa ' (1997 ) 113 Gastroenterology : 1660 -1667.

    • Search Google Scholar
  • Ikeda, K., Saitoh, S., Suzuki, Y. és mtsai: Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study. Cancer, 1998, 82 , 827–835.

    Suzuki Y. , 'Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study ' (1998 ) 82 Cancer : 827 -835.

    • Search Google Scholar
  • Lin, S. M., Sheen, I. S., Chien, R. N. és mtsai: Long-term follow-up of interferon alfa therapy in patients with chronic hepatitis B virus infection. Hepatology, 1999, 29 , 971–975.

    Chien R. N. , 'Long-term follow-up of interferon alfa therapy in patients with chronic hepatitis B virus infection ' (1999 ) 29 Hepatology : 971 -975.

    • Search Google Scholar
  • Papatheodoridis, G., Manesis, E. K., Hadziyannis, S. J.: The long term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B. J. Hepatol., 2001, 34 , 306–313.

    Hadziyannis S. J. , 'The long term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B ' (2001 ) 34 J. Hepatol. : 306 -313.

    • Search Google Scholar
  • Yuen, M. F., Hui, C. K., Cheng, C. C. és mtsai: Long-term follow-up of interferon alpha treatment in Chinese patients with chronic hepatitis B infection: The effect of hepatitis B e antigen seroconversion and the development of cirrhosis related complications. Hepatology, 2001, 34 , 139–145.

    Cheng C. C. , 'Long-term follow-up of interferon alpha treatment in Chinese patients with chronic hepatitis B infection: The effect of hepatitis B e antigen seroconversion and the development of cirrhosis related complications ' (2001 ) 34 Hepatology : 139 -145.

    • Search Google Scholar
  • Lampertico, P., Del Ninno, E., Vigano, M. és mtsai: Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy. Hepatology, 2003, 37 , 756–763.

    Vigano M. , 'Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy ' (2003 ) 37 Hepatology : 756 -763.

    • Search Google Scholar
  • Chen, C-JC., Yang, H-I., Su, J. és mtsai: Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA, 2006, 295 , 65–73.

    Su J. , 'Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level ' (2006 ) 295 JAMA : 65 -73.

    • Search Google Scholar
  • Lim, C. Y., Kowdley, K. V.: Optimal duration of therapy in HBV-related cirrhosis. J. Antimicrobial Chemother., 2007, 60 , 2–6.

    Kowdley K. V. , 'Optimal duration of therapy in HBV-related cirrhosis ' (2007 ) 60 J. Antimicrobial Chemother. : 2 -6.

    • Search Google Scholar
  • Fung, S. K., Lok, A. S. F.: Management of patients with hepatitis B virus induced cirrhosis. J. Hepatol., 2005, 42 , S54–S64.

    Lok A. S. F. , 'Management of patients with hepatitis B virus induced cirrhosis ' (2005 ) 42 J. Hepatol. : S54 -S64.

    • Search Google Scholar
  • Liaw, Y. F., Sung, J. J., Chow, W. C. és mtsai: Lamivudine for patients with chronic hepatitis B and advanced liver disease. N. Eng. J. Med., 2004, 351 , 1521–1531.

    Chow W. C. , 'Lamivudine for patients with chronic hepatitis B and advanced liver disease ' (2004 ) 351 N. Eng. J. Med. : 1521 -1531.

    • Search Google Scholar
  • Lai, C-L., Leung, N., Teo, E-K. és mtsai: A 1-year trial of telbivudine, lamivudin, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B. Gastroenterology, 2005, 129 , 528–536.

    Teo E-K. , 'A 1-year trial of telbivudine, lamivudin, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B ' (2005 ) 129 Gastroenterology : 528 -536.

    • Search Google Scholar
  • European Association for the Study of the Liver: EASL Clinical Practice Guidelines. Management of chronic hepatitis B. J. Hepatol., 2009, 50 , DOI:10.1016/j.jhep.2008.10.001

    'EASL Clinical Practice Guidelines. Management of chronic hepatitis B ' (2009 ) J. Hepatol. : -.

    • Search Google Scholar
  • Huang, R. H., Hu, K-Q.: A practical approach to managing patients with HCV infection. Int. J. Med. Sci., 2006, 3 , 63–68.

    Hu K-Q. , 'A practical approach to managing patients with HCV infection ' (2006 ) 3 Int. J. Med. Sci. : 63 -68.

    • Search Google Scholar
  • Mazzella, G., Accogli, E., Sottili, S. és mtsai: Alfa interferon treatment may prevent HCC in HCV-related liver cirrhosis. J. Hepatol., 1996, 24 , 141–147.

    Sottili S. , 'Alfa interferon treatment may prevent HCC in HCV-related liver cirrhosis ' (1996 ) 24 J. Hepatol. : 141 -147.

    • Search Google Scholar
  • Gramenzini, A., Andreone, P., Fiorino, S. és mtsai: Impact of interferon therapy on the natural history of HCV related cirrhosis. Gut, 2001, 48 , 843–848.

    Fiorino S. , 'Impact of interferon therapy on the natural history of HCV related cirrhosis ' (2001 ) 48 Gut : 843 -848.

    • Search Google Scholar
  • Yoshida, H., Shiatori, Y., Moriyama, M. és mtsai: Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann. Intern. Med., 1999, 131 , 174–181.

    Moriyama M. , 'Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan ' (1999 ) 131 Ann. Intern. Med. : 174 -181.

    • Search Google Scholar
  • Shiatori, Y., Ito, Y., Yokosuka, O. P. és mtsai: Antiviral therapy for chronic hepatitis C. Association with reduced hepatocellular carcinoma development and improved survival. Ann. Intern. Med., 2005, 142 , 105–114.

    Yokosuka O. P. , 'Antiviral therapy for chronic hepatitis C. Association with reduced hepatocellular carcinoma development and improved survival ' (2005 ) 142 Ann. Intern. Med. : 105 -114.

    • Search Google Scholar
  • Benvegnu, I., Gios, M., Bocato, S. és mtsa: Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut, 2004, 53 , 744–749.

    Bocato S. , 'Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications ' (2004 ) 53 Gut : 744 -749.

    • Search Google Scholar
  • Arase, Y., Ikeda, K., Suzuki, F. és mtsai: Prolonged interferon therapy reduces hepatocarcinogenesis in aged patients with chronic hepatitis C. J. Med. Virol., 2007, 79 , 1095–1102.

    Suzuki F. , 'Prolonged interferon therapy reduces hepatocarcinogenesis in aged patients with chronic hepatitis C ' (2007 ) 79 J. Med. Virol. : 1095 -1102.

    • Search Google Scholar
  • Hung, C-H., Lee, C-M., Lu, S-N. és mtsai: Long-term effect of interferon alfa-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis. J. Viral. Hepat., 2006, 13 , 409–414.

    Lu S-N. , 'Long-term effect of interferon alfa-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis ' (2006 ) 13 J. Viral. Hepat. : 409 -414.

    • Search Google Scholar
  • El Braks, R., Ganne-Carié, N., Fontaine, H. és mtsai: Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin. World J. Gastroenterol., 2007, 13 , 5648–5653.

    Fontaine H. , 'Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin ' (2007 ) 13 World J. Gastroenterol. : 5648 -5653.

    • Search Google Scholar
  • Sinn, D. H., Paik, S. W., Kang, P. és mtsai: Disease progression and the risk factor analysis for chronic hepatitis C. Liver Internat., 2008, 28 , 1363–1369.

    Kang P. , 'Disease progression and the risk factor analysis for chronic hepatitis C ' (2008 ) 28 Liver Internat. : 1363 -1369.

    • Search Google Scholar
  • Sheldon, J., Barreiro, P., Vincent, V.: Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection. Expert Opin. Investig. Drugs, 2007, 16 , 1171–118.

    Vincent V. , 'Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection ' (2007 ) 16 Expert Opin. Investig. Drugs : 1171 -118.

    • Search Google Scholar
  • Thomas, E., Frid, M. W.: Hepatitis C: Current options for nonresponders to peginterferon and ribavirin. Curr. Gastroenterol. Rep., 2008, 10 , 53–59.

    Frid M. W. , 'Hepatitis C: Current options for nonresponders to peginterferon and ribavirin ' (2008 ) 10 Curr. Gastroenterol. Rep. : 53 -59.

    • Search Google Scholar
  • Lawitz, E., Torres, M., Muir, A. J. és mtsai: Antiviral effects and safety of telaprevir, peginterferon alfa-2a and ribavirin for 28 days in hepatitis C patients. J. Hepatol., 2008, 49 , 163–169.

    Muir A. J. , 'Antiviral effects and safety of telaprevir, peginterferon alfa-2a and ribavirin for 28 days in hepatitis C patients ' (2008 ) 49 J. Hepatol. : 163 -169.

    • Search Google Scholar
  • Di Bisceglie, A. M., Hoofnagle, J. H.: Elevations in serum alfa-fetoprotein levels in patients with chronic hepatitis B. Cancer, 1989, 64 , 2117–2120.

    Hoofnagle J. H. , 'Elevations in serum alfa-fetoprotein levels in patients with chronic hepatitis B ' (1989 ) 64 Cancer : 2117 -2120.

    • Search Google Scholar
  • Colombo, M., de Franchis, R., Del Ninno, E. és mtsai: Hepatocellular carcinoma in Italian patients with cirrhosis. N. Eng. J. Med., 1991, 325 , 675–680.

    Ninno E. , 'Hepatocellular carcinoma in Italian patients with cirrhosis ' (1991 ) 325 N. Eng. J. Med. : 675 -680.

    • Search Google Scholar
  • Solmi, L., Primerano, A. M., Gandolfi, L.: Ultrasound follow-up of patients at risk for hepatocellular carcinoma: result of a prospective study on 360 cases. Amer. J. Gastroenterol., 1996, 91 , 1189–1194.

    Gandolfi L. , 'Ultrasound follow-up of patients at risk for hepatocellular carcinoma: result of a prospective study on 360 cases ' (1996 ) 91 Amer. J. Gastroenterol. : 1189 -1194.

    • Search Google Scholar
  • Izzo, F., Cremona, F., Ruffolo, F. és mtsai: Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Ann. Surg., 1998, 227 , 513–518.

    Ruffolo F. , 'Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis ' (1998 ) 227 Ann. Surg. : 513 -518.

    • Search Google Scholar
  • Gebo, K. A., Chander, G., Jenckes, M. W. és mtsa: Screening test for hepatocellular carcinoma in patients with chronic hepatits C: a systematic review. Hepatology, 2002, 36 (Suppl. 1) , 84–92.

    Jenckes M. W. , 'Screening test for hepatocellular carcinoma in patients with chronic hepatits C: a systematic review ' (2002 ) 36 Hepatology : 84 -92.

    • Search Google Scholar
  • Lopez, J. B.: Recent developments in the first detection of hepatocellular carcinoma. Clin. Biochem. Rev., 2005, 26 , 65–79.

    Lopez J. B. , 'Recent developments in the first detection of hepatocellular carcinoma ' (2005 ) 26 Clin. Biochem. Rev. : 65 -79.

    • Search Google Scholar
  • Tanaka, H., Nouso, K., Kobashi, H. és mtsai: Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival. Liver Internat., 2006, 26 , 543–551.

    Kobashi H. , 'Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival ' (2006 ) 26 Liver Internat. : 543 -551.

    • Search Google Scholar
  • Bruix, J., Sherman, M., Llovet, J. M. és mtsai: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL Conference. J. Hepatol., 2001, 35 , 421–430.

    Llovet J. M. , 'Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL Conference ' (2001 ) 35 J. Hepatol. : 421 -430.

    • Search Google Scholar
  • Ikeda, M., Fujiyama, S., Tanaka, M. és mtsai: Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C. J. Gastroenterol. Hepatol., 2006, 28 , 122–128.

    Tanaka M. , 'Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C. J. Gastroenterol ' (2006 ) 28 Hepatol. : 122 -128.

    • Search Google Scholar
  • Kobayashi, S., Takeda, T., Enomoto, M. és mtsai: Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients. Liver Internat., 2007, 27 , 186–191.

    Enomoto M. , 'Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients ' (2007 ) 27 Liver Internat. : 186 -191.

    • Search Google Scholar
  • Altorjai I.: A májbetegségek szűrésének lehetőségei. Eur. J. Gastroenterol. Hepatol., 2007, 11 , 201–204.

    Altorjai I. , 'A májbetegségek szűrésének lehetőségei ' (2007 ) 11 Eur. J. Gastroenterol. Hepatol. : 201 -204.

    • Search Google Scholar
  • Kubo, S., Nischiguchi, S., Hirohashi, K. és mtsai: Effect of long term postoperative interferon alfa therapy on intrahepatic recurrescence after resection of hepatitis C virus related hepatocellular carcinoma. Ann. Intern. Med., 2001, 134 , 963–967.

    Hirohashi K. , 'Effect of long term postoperative interferon alfa therapy on intrahepatic recurrescence after resection of hepatitis C virus related hepatocellular carcinoma ' (2001 ) 134 Ann. Intern. Med. : 963 -967.

    • Search Google Scholar
  • Nishiguchi, S., Shiomi, S., Nakatani, S. és mtsai: Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis. Lancet, 2001, 357 , 196–197.

    Nakatani S. , 'Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis ' (2001 ) 357 Lancet : 196 -197.

    • Search Google Scholar
  • Lo, C. M., Liu, C. L., Chan, S. C. és mtsai: A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann. Surg., 2007, 245 , 831–842.

    Chan S. C. , 'A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma ' (2007 ) 245 Ann. Surg. : 831 -842.

    • Search Google Scholar
  • Kim, B. K., Park, J. Y., Kim, D. Y. és mtsai: Persistent hepatitis B viral replication affects recurrescence of hepatocellular carcinoma after curative resection. Liver Internat., 2008, 28 , 393–401.

    Kim D. Y. , 'Persistent hepatitis B viral replication affects recurrescence of hepatocellular carcinoma after curative resection ' (2008 ) 28 Liver Internat. : 393 -401.

    • Search Google Scholar
  • Ikeda, K., Arase, Y., Saitoh, S. és mtsai: Interferon beta prevents recurrescence of hepatocellular carcinoma after complete resection or ablation of the primary tumor. A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology, 2000, 32 , 228–232.

    Saitoh S. , 'Interferon beta prevents recurrescence of hepatocellular carcinoma after complete resection or ablation of the primary tumor. A prospective randomized study of hepatitis C virus-related liver cancer ' (2000 ) 32 Hepatology : 228 -232.

    • Search Google Scholar
  • Jeong, S. C., Aikata, H., Katamura, Y. és mtsai: Effects of a 24-week course of interferon-α therapy after curative treatment of hepatitis C virus associated hepatocellular carcinoma. World J. Gastroenterol., 2007, 13 , 5343–5350.

    Katamura Y. , 'Effects of a 24-week course of interferon-α therapy after curative treatment of hepatitis C virus associated hepatocellular carcinoma ' (2007 ) 13 World J. Gastroenterol. : 5343 -5350.

    • Search Google Scholar
  • Wimmer A., Fehér J., Lengyel G.: Hepatitis C-vírus sikeres eliminálása hepatocellularis carcinoma miatti lobectomiát követően. Orv. Hetil., 2008, 149 , 2143–2148.

    Lengyel G. , 'Hepatitis C-vírus sikeres eliminálása hepatocellularis carcinoma miatti lobectomiát követően ' (2008 ) 149 Orv. Hetil. : 2143 -2148.

    • Search Google Scholar
  • Chen, L. T., Chen, M. F., Lee, L. A. és mtsai: Randomized phase III study of adjuvant interferon alfa-2b in hepatocellular carcinoma with curative resection – the Taiwan Cooperative Oncology Group (TCOG T1297) Study. Hepatology, 2005, 42 , 237–238A.

    Lee L. A. , 'Randomized phase III study of adjuvant interferon alfa-2b in hepatocellular carcinoma with curative resection – the Taiwan Cooperative Oncology Group (TCOG T1297) Study ' (2005 ) 42 Hepatology : 237 -238A.

    • Search Google Scholar
  • Clavien, P. A.: Interferon: the magic bullet to prevent hepatocellular carcinoma recurrescence after resection? Ann. Surg., 2007, 245 , 843–845.

    Clavien P. A. , 'Interferon: the magic bullet to prevent hepatocellular carcinoma recurrescence after resection? ' (2007 ) 245 Ann. Surg. : 843 -845.

    • Search Google Scholar